Table 3.
Ex vivo anti-rotavirus Ig producing spleen and mesenteric lymph node (MLN) cells from 28-day-old animals from SA11 and double-infected (SA11 and EDIM) groups with dietary intervention.
| SA11 infection |
SA11 and EDIM infections |
|||
|---|---|---|---|---|
| Spleen | MLN | Spleen | MLN | |
| REF | 204.7 ± 40.8 | 245.1 ± 43.9 | 204.7 ± 40.8 | 245.1 ± 43.9 |
| DRI | 228.0 ± 21.2 | 318.3 ± 36.3 | 302.9 ± 18.5* | 296.7 ± 29.3 |
| EDIM | – | – | 223.4 ± 34.6 | 205.5 ± 36.7 |
| HBC | 340.0 ± 75.1*,# | 443.3 ± 43.3*,# | 242.6 ± 51.1 | 215.1 ± 42.9 |
| PRE | 435.1 ± 72.1*,# | 188.3 ± 16.4# | 253.1 ± 23.4 | 246.0 ± 26.9 |
| PRO | 356.7 ± 114.0*,# | 320.0 ± 45.8 | 174.6 ± 46.0# | 216.5 ± 51.9 |
| SYN | 396.7 ± 112.7*,# | 375.0 ± 62.1*,# | 250.9 ± 57.3 | 276.2 ± 54.8 |
Results are expressed as mean Ig-SC/106 cells ± SEM (n = 3–12 animals/group).
Statistical differences: *p < 0.05 vs. REF; #p < 0.05 vs. SA11 or DRI.
Groups: REF, reference; DRI, double rotavirus infected; HBC, hyperimmune bovine colostrum; PRE, prebiotic; PRO, probiotic; SYN, synbiotic.